A comprehensive view of Pediatrics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
GlobalData: Sanofi and Regeneron’s additional label expansion for Dupixent reinforces its dominance in atopic dermatitis market; Dupixent expected to reach sales of US$5.3B in US by 2030, showcasing its blockbuster potential in a lucrative market
Published:
July 05, 2022
by GlobalData Plc
|
Ballad Health starts first phase of construction on US$30M J.D. Nicewonder Family Perinatal and Pediatric Institute at Niswonger Children's Hospital in Johnson City, Tennessee; phase two to add two-floor addition to house neonatal intensive care unit
Published:
June 21, 2022
by Targeted News Service (Press Releases)
|
Annual number of unintentional pediatric ingestions of melatonin increased 530% from 2012 to 2021 to total of 260,436 ingestions; hospitalizations, serious outcomes in kids aged 5 or younger increased during study period, with two deaths: study
Published:
June 13, 2022
by The Breeze (James Madison University)
|
Regeneron and Sanofi’s injectable anti-inflammatory drug Dupixent dupilumab cleared in US to treat children six months to five years old with atopic dermatitis or eczema; drug had previously been approved for children aged six years and older
Published:
June 10, 2022
by SeeNews Pharmaceuticals
|
Masimo PVi may give ER doctors noninvasive tool to determine severity of asthma attacks in pediatric patients; acute asthma attacks are a common cause of admission to emergency departments among children: study
Published:
May 26, 2022
by Business Wire
|
Ask us about our R&D/Patents market view
Trending Chart
Interactive chart with headline count